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Hepatoprotective role of Sestrin2 against
chronic ER stress
Hwan-Woo Park1, Haeli Park1, Seung-Hyun Ro1, Insook Jang1, Ian A. Semple1, David N. Kim1,
Myungjin Kim1, Myeongjin Nam1,2, Deqiang Zhang1, Lei Yin1 & Jun Hee Lee1
Upon prolonged endoplasmic reticulum (ER) stress, cells attenuate protein translation to
prevent accumulation of unfolded proteins. Here we show that Sestrin2 is critical for this
process. Sestrin2 expression is induced by an ER stress-activated transcription factor CCAAT-
enhancer-binding protein beta (c/EBPb). Once induced, Sestrin2 halts protein synthesis by
inhibiting mammalian target of rapamycin complex 1 (mTORC1). As Sestrin2-deficient cells
continue to translate a large amount of proteins during ER stress, they are highly susceptible
to ER stress-associated cell death. Accordingly, dietary or genetically induced obesity, which
does not lead to any pathological indication other than simple fat accumulation in the liver of
wild-type (WT) mice, can provoke Sestrin2-deficient mice to develop severe ER stress-
associated liver pathologies such as extensive liver damage, steatohepatitis and fibrosis.
These pathologies are suppressed by liver-specific Sestrin2 reconstitution, mTORC1 inhibition
or chemical chaperone administration. The Sestrin2-mediated unfolded protein response
(UPR) may be a general protective mechanism against ER stress-associated diseases.
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E
xcessive hepatic fat accumulation during obesity and non-
alcoholic fatty liver disease (NAFLD) can induce chronic
endoplasmic reticulum (ER) stress, a perturbation in ER
homeostasis that can lead to hepatocyte death and a subsequent
series of liver inflammation, oxidative stress accumulation and
fibrosis collectively known as non-alcoholic steatohepatitis
(NASH)1,2. However, the progression from simple
hepatosteatosis to NASH does not occur rapidly in most
experimental models and human clinical cases of obesity. For
example, although overnutrition in rodents, caused by high-fat
diet (HFD) feeding or leptin deficiency, can result in obesity and
hepatosteatosis, it does not spontaneously provoke steatohepatitis
or fibrosis without further liver injury3,4. In humans, a substantial
portion of the population with obesity and hepatosteatosis shows
fairly stable NAFLD symptoms for a prolonged period without
progressing to NASH5. This attenuation of NASH development
can be due to the existence of protective mechanisms that
suppress obesity-associated ER stress.
A mechanism that protects cells against ER stress is generally
defined as unfolded protein response (UPR)6. Perturbation of ER
homeostasis leads to activation of three transmembrane ER stress
sensor molecules: protein kinase RNA-like ER kinase (PERK),
inositol-requiring enzyme 1 (IRE1) and activating transcription
factor 6 (ATF6). These ER stress sensors together initiate
protective UPR that increases molecular chaperone levels,
attenuates protein synthesis and ER protein loading and
upregulates ER-associated protein degradation and ER
membrane biosynthesis. However, persistent and robust ER
stress that exceeds the capacity of protective UPR may lead to cell
death through apoptotic signalling activation7 or ATP depletion8.
The failure in protective UPR and the subsequent induction of
ER stress-induced cell death are detrimental to physiological
homeostasis, and these damages have been implicated in diverse
degenerative diseases associated with obesity9. However, the
detailed molecular mechanisms underlying the protective UPR
have not been completely understood yet.
Sestrins are a family of stress-inducible proteins that can
suppress mammalian target of rapamycin complex 1 (mTORC1)
through activation of AMP-activated protein kinase (AMPK)10,11.
Sestrins are necessary for maintaining metabolic homeostasis and
preventing age- and obesity-associated pathologies11–13. Among
the three Sestrin homologues in mammals (Sestrin1–3), we
recently found that, through unknown mechanisms, Sestrin2
expression in the liver becomes elevated upon hypernutrition
and obesity and functions to alleviate insulin resistance and
hepatosteatosis12. Here we show that Sestrin2 is transcriptionally
induced through the PERK–c/EBPb (CCAAT-enhancer-binding
protein beta) pathway upon obesity-associated ER stress and
maintains hepatic ER homeostasis by suppressing mTORC1-
dependent protein translation. Correspondingly, loss of Sesn2
allows for persistent protein synthesis in hepatocytes even under
chronic ER stress, which further exacerbates the level of ER stress
and subsequently results in extensive NASH-like pathologies such
as liver damage, inflammation and fibrosis. Our results suggest
that Sestrin2 critically mediates hepatocellular adaptation to ER
stress and that Sestrin2 is the endogenous attenuator of NAFLD
progression that operates primarily through maintaining ER
homeostasis.
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Figure 1 | Obesity induces Sestrin2 through ER stress signalling. (a–c) HepG2 cells were treated with PA for indicated hours and analysed by
immunoblotting (images with black bands) and RT–PCR (images with white bands). P values were calculated between untreated (0 h) and indicated groups
(b,c; n¼ 3). (d,e) At 48 h after infection with green fluorescent protein (GFP; Con)- or SERCA2b-overexpressing adenoviruses, cells were treated with BSA
(0 h) or PA for indicated hours (d) or 9 h (e; n¼ 3). (f,g,l,m) Six-month-old WTmice kept on low-fat diet (LFD) or HFD for 4 months were injected daily
with vehicle (phosphate-buffered saline (PBS)) or TUDCA (500mg per kg body weight i.p.) or transduced once with adenoviruses expressing SERCA2b,
GFP (Con) or shRNA targeting c/EBPb. After 10 days, livers were analysed by immunoblotting (n¼ 3). (h,k) At 48 h before PA treatment, cells were
infected with lentiviruses expressing shRNAs targeting luciferase (Con), PERK (h) and c/EBPb (k). After 9 h of BSA ( ) or PA treatment, cells were
analysed by immunoblotting. (i,j) ChIP analysis of cells with indicated treatments (n¼ 3). (n) At 24 h after infection with GFP (Con)- or c/EBPb-
overexpressing adenoviruses, cells were analysed by immunoblotting. All data are shown as the mean±s.e.m. P values are from Student’s t-test. Molecular
weight markers are indicated in kDa (immunoblots) or bp (agarose gels).
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Results
Induction of Sestrin2 expression by ER stress insults. To
understand how Sestrin2 expression is induced upon obesity, we
subjected the human HepG2 cells to a series of culture environ-
ments that could mimic the conditions during obesity. As a result,
we found that saturated fatty acids (SFAs) such as palmitic acid
(PA) or stearic acid induced prominent accumulation of Sestrin2
mRNA and protein (Fig. 1a–c and Supplementary Fig. 1a). In
contrast, unsaturated fatty acids such as oleic acid or doc-
osahexaenoic acid not only failed to induce this upregulation
(Supplementary Fig. 1b,c) but actually suppressed the effect of
SFA (Supplementary Fig. 1d,e). Interestingly, the patterns of
Sestrin2 expression were almost entirely correlated with the
patterns of ER stress signalling activation that was monitored by
PERK phosphorylation, c/EBP homologous protein (CHOP)
expression and X-box binding protein 1 (XBP1) splicing (Fig. 1a
and Supplementary Fig. 1a–e). Chemical ER stress inducers such
as tunicamycin (Tm) or thapsigargin also induced Sestrin2
expression in HepG2 cells (Supplementary Fig. 1f,g) and mouse
liver (Supplementary Fig. 1h).
Obesity induces Sestrin2 through ER stress signalling. Over-
expression of sarco-ER calcium pump 2b (SERCA2b) or admin-
istration of a chemical chaperone tauroursodeoxycholic acid
(TUDCA), either of which can substantially reduce hepatic ER
stress14–16, was able to halt Sestrin2 induction caused by SFA
(Fig. 1d,e; in HepG2 cells) or HFD-induced obesity (Fig. 1f,g and
Supplementary Fig. 1i–k; in mouse liver). On the contrary, other
known regulators of the Sestrin-family gene expression, such as
oxidative stress, c-Jun N-terminal kinase (JNK), p53 or mTORC1,
were not involved in Sestrin2 induction during obesity;
antioxidants, SP600125, p53-shRNA (p53-short-hairpin RNA)
and rapamycin failed to suppress SFA- or obesity-induced
Sestrin2 expression (Supplementary Fig. 1l–x). Thus, we
concluded that obesity increases Sestrin2 expression primarily
through activation of ER stress signalling.
PERK–c/EBPb axis mediates Sestrin2 induction upon ER
stress. We next searched for a molecular mechanism by which the
ER stress signal could be sensed and transmitted to induce Ses-
trin2 expression upon obesity. Inhibition of an ER stress sensor
PERK, but not that of the other two sensors IRE1 and ATF6,
abolished the ability of SFA to induce Sestrin2 (Fig. 1h and
Supplementary Fig. 2a,b). ATF4 and CHOP, the two
most well-characterized transcription factors downstream of
PERK6, were not involved in SFA-induced Sestrin2 expression
(Supplementary Fig. 2c,d), whereas c/EBPb, another transcription
factor downstream of PERK17,18 whose active isoform (LAP)
accumulates inside the nucleus (Supplementary Fig. 2e,f) and
binds to the Sesn2 promoter upon ER stress insults (Fig. 1i,j and
Supplementary Fig. 2g,h), was both necessary and sufficient to
induce SFA- or obesity-induced Sestrin2 expression (Fig. 1k–n).
These results indicate that the PERK–c/EBPb signalling pathway
controls Sestrin2 expression during obesity-associated ER stress.
Sestrin2 links ER stress and AMPK-mTORC1 regulation.
Several recent studies indicate that chronic ER stress suppresses
mTORC1 through an unknown mechanism that involves the acti-
vation of PERK and AMPK19,20. Our findings here regarding the ER
stress-induced Sestrin2 expression suggest that Sestrin2 may be the
unknown moderator that bridges ER stress signalling and mTORC1
function. Indeed, Sestrin2-deficient cells and tissues could not
activate AMPK or inhibit mTORC1 signalling upon SFA- (Fig. 2a–e)
or Tm-induced ER stress (Fig. 2f–h). The signalling misregulation
was not due to defects in energy homeostasis as cellular ATP levels
were not significantly altered by either Sestrin2 deficiency or ER
stress insults (Fig. 2i,j). These results demonstrate that mTORC1
suppression during ER stress is dependent on Sestrin2.
Sestrin2 attenuates translation during chronic ER stress.
Although PERK-mediated eukaryotic translation initiation factor
2a (eIF2a) phosphorylation can halt protein translation during
the early phase of ER stress, this inhibitory effect is only tem-
porary and quickly diminished during prolonged ER stress6,8.
Paradoxically, other ER stress signalling components downstream
of PERK and eIF2a, such as ATF4 and CHOP, were found to
increase protein synthesis and antagonize the effect of eIF2a
phosphorylation8. Considering that mTORC1 is a major
regulator of protein translation, Sestrin2-mediated mTORC1
suppression that occurs during ER stress may provide an
alternative explanation for the inhibition of protein translation.
During the early phase of ER stress (within 3 h of SFA treatment),
Sestrin2-deficient cells properly ceased protein translation
similarly to control cells (Supplementary Fig. 3a,b). However,
after 9 h of SFA-induced ER stress, Sestrin2-deficient HepG2 cells
and mouse primary hepatocytes continued to translate large
amounts of proteins, while control cells managed to cease
protein synthesis under the same condition (Fig. 2k–n and
Supplementary Fig. 3a–c), suggesting that Sestrin2 is indeed
critical for protein synthesis regulation during chronic ER stress.
Similarly, Sesn2 / mice could not downregulate hepatic
protein synthesis upon 24 h of Tm treatment or 2 months of
HFD feeding (Fig. 2o–r and Supplementary Fig. 3d–g) in contrast
to wild-type (WT) mice8,15. On the other hand, mTORC1
inhibition by Sestrin2 overexpression or rapamycin treatment
was sufficient to suppress protein translation (Supplementary
Fig. 3h,i) without inducing eIF2a phosphorylation or ATF4
expression (Supplementary Fig. 3j,k). Therefore, Sestrin2 is a
critical mediator of UPR that halts mTORC1-dependent protein
translation during chronic ER stress.
Sestrin2 deficiency aggravates ER stress during obesity.
Cessation of protein translation is critical for decreasing ER
protein load and preventing accumulation of unfolded proteins.
Thus, we were curious whether Sestrin2 was necessary for
resolution of ER stress after insults. Sestrin2 deficiency strongly
exacerbated SFA-induced ER stress in HepG2 cells and mouse
primary hepatocytes, as evidenced by increased phosphorylation
of PERK and eIF2a and upregulation of ER stress-induced
gene expression (Supplementary Fig. 4a–d). Sesn2 / mice
also exhibited extensive aggravation of ER stress, either upon
Tm treatment- (Fig. 3a,b and Supplementary Fig. 4e–g),
HFD- (Fig. 3c–f and Supplementary Fig. 4h,i) or Lepob mutation-
induced obesity (Fig. 3g–i and Supplementary Fig. 4j). Hyper-
activated ER stress signalling in obese Sesn2 / mouse liver was
completely suppressed by liver-specific transduction of Sestrin2
(Supplementary Fig. 5a–d), suggesting that Sestrin2 suppresses
hepatic ER stress in a tissue-autonomous manner.
Sestrin2 controls ER homeostasis through AMPK-mTORC1.
Sestrin2 has two independent biological activities largely divided
into regulating the AMPK-mTORC1 signalling and suppressing
the reactive oxygen species (ROS) accumulation11. We found
that, in Sestrin2-silenced cells, ER stress was strongly reduced
by aminoimidazole carboxamide ribonucleotide (AICAR, an
activator of AMPK) and rapamycin as well as by another
mTORC1 inhibitor PP242 and a translation inhibitor
cycloheximide (Fig. 4a–c and Supplementary Fig. 6a,b), while
treatment of antioxidants such as BHA and N-acetylcysteine
turned out to be ineffective (Fig. 4b,c). Inhibition of mTORC1 by
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Raptor-shRNA also ameliorated excessive ER stress signalling in
Sestrin2-deficient cells (Fig. 4d,e), while mTORC1 activation by
TSC2-shRNA exacerbated PA-induced ER stress (Fig. 4f,g).
In liver of obese Sesn2 / mice, liver-specific AMPKCA
transduction or systemic AICAR administration was sufficient
to suppress ER stress signalling (Fig. 4h–k and Supplementary
Fig. 6c,d). Consistent with the known roles of mTORC1
in regulating protein translation, AICAR, rapamycin and
cycloheximide all suppressed protein translation in SFA-treated
Sestrin2-deficient cells (Supplementary Fig. 6e,f), whereas TSC2
inhibition upregulated protein synthesis in SFA-treated control
cells (Supplementary Fig. 6g,h). We also tested whether
alleviation of protein synthesis through the eIF2a pathway
could reduce ER stress in Sesn2 / mice. Salubrinal, a specific
inhibitor of eIF2a dephosphorylation21 (Supplementary
Fig. 7a,b), substantially suppressed ER stress in livers of
Sesn2 / mice (Supplementary Fig. 7c–e). Taken together, our
findings indicate that Sestrin2 maintains ER homeostasis
primarily through regulation of the AMPK-mTORC1-protein
synthesis signalling pathway.
Sestrin2 is required to prevent liver damage during obesity. As
excessive ER stress can result in cell death7,8, we examined
whether Sestrin2 is required for ensuring cell’s viability during ER
stress insults. Upon prolonged SFA treatment for 16–24 h,
Sestrin2-deficient HepG2 cells and mouse primary hepatocytes
exhibited remarkably increased apoptotic cell death compared
with control cells (Supplementary Fig. 8a–d), consistent with
heightened ER stress level (Supplementary Fig. 4a–d). Sesn2 /
mouse liver, upon Tm-induced ER stress, also exhibited more
severe liver damage manifested by ectopic hepatocyte apoptosis
and substantial elevation in serum alanine aminotransferase
(ALT) levels compared with WT mouse liver (Supplementary
Fig. 8e–g). More strikingly, HFD- or Lepob-induced obesity,
which by itself does not induce any liver damage in WT mice,
provoked Sesn2 / mice to exhibit extensive hepatocyte death
(Fig. 5a,b) and prominently elevated ALT levels (Fig. 5c), both of
which were completely resolved by liver-specific reconstitution of
Sestrin2 (Fig. 5d–f). TUDCA and salubrinal also effectively
suppressed liver damage of obese or Tm-treated Sesn2 / mice
(Fig. 5g–i and Supplementary Fig. 7f,g), suggesting that
unresolved hepatic ER stress is the main cause of the liver
damage observed. These data collectively highlight Sestrin2 as a
critical hepatoprotective agent that prevents hepatocyte apoptosis
and liver damage upon both acute and chronic ER stress.
Sestrin2 is an endogenous attenuator of steatohepatitis. We
found that dying hepatocytes in the liver of obese Sesn2 / mice
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Figure 2 | Sestrin2 suppresses mTORC1 and protein synthesis in response to ER stress. (a–e) At 48 h after infection with shRNA lentiviruses for
luciferase (Con) or Sestrin2, HepG2 cells were treated with PA for 9 h and analysed by immunoblotting (n¼ 3). AMPK signalling activity was monitored by
phosphorylation of AMPK and acetyl-CoA carboxylase (ACC). mTORC1 signalling activity was monitored by phosphorylation of p70 ribosomal S6K,
ribosomal protein S6 and eIF4E-binding protein (4E-BP). (f–h) Two-month-old WTor Sesn2 / mice kept on LFD were injected with Tm (500mg per kg
body weight i.p.). After indicated hours, livers were analysed by immunoblotting (n¼4). (i,j) Relative intracellular ATP levels of indicated cells (i, n¼ 3) and
liver tissues (j, n¼4). As a positive control for ATP depletion, HepG2 cells were treated with oligomycin (OM, 5 mgml 1) for 1 h. (k–r) HepG2 cells
transduced with sh-Con or sh-Sesn2 (k,m, n¼ 5) or primary hepatocytes (1-HPC) isolated from WTor Sesn2 / mice (l,n, n¼4) were treated with BSA
( ) or PA for 9 h. Two-month-old WTor Sesn2 / mice were injected with Tm (o,q, n¼4) or kept on LFD or HFD for additional 2 months (p,r, n¼4).
After indicated treatments, newly synthesized proteins in cells (k–n) and liver tissues (o–r) were visualized and quantified using the Click-IT AHA labelling
system. The protein bands denoted by stars correspond to serum albumin (70 kD), which is the most actively synthesized protein in normal hepatocytes.
All data are shown as the mean±s.e.m. P values are from Student’s t-test. Molecular weight markers are indicated in kDa.
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were frequently associated with aggregation of dense-nucleated
cells (Supplementary Fig. 9a), most of which were identified as
F4/80-positive macrophages (Supplementary Fig. 9b). Some of
the aggregated macrophages were proliferative as judged from
positive BrdU staining (Supplementary Fig. 9c). As a result, the
liver of obese Sesn2 / mice accumulated a highly increased
number of macrophages (Fig. 6a,b), and these characteristics
clearly imply the occurrence of active steatohepatitis. The
steatohepatitis phenotype was completely suppressed by liver-
specific Sestrin2 reconstitution (Fig. 6c,d), TUDCA administra-
tion (Fig. 6e,f) and AMPK reactivation (Fig. 6g,h). In
addition, Sesn2 loss also aggravated Tm-induced steatohepatitis
(Supplementary Fig. 9d,e).
Sestrin2 deficiency provokes liver fibrosis in obese mice.
Hepatocyte death and subsequent activation of liver inflamma-
tion can lead to activation of hepatic stellate cells (HSCs) that are
known to secrete collagen. Although the liver from obese
WT mice only displayed a few activated HSCs, visualized with
alpha-smooth muscle actin (a-SMA) staining, the liver from
obese Sesn2 / mice contained a substantially increased number
of activated HSCs (Supplementary Fig. 9f,g). Consistent with this
finding, there was a significant increase in collagen deposition in
the liver from obese Sesn2 / mice (Supplementary Fig. 9h,i),
validating the occurrence of liver fibrosis. Extensive fibrosis
observed in the Lepob/ob/Sesn2 / mouse liver was particularly
striking because Lepob/ob mutant mice were reported to be
very resistant to liver fibrosis3. Taken together, these data
collectively indicate that, during obesity, Sestrin2-mediated ER
stress suppression is critical for preventing NASH-like liver
pathologies including fibrosis (Fig. 6i,j).
Sestrin2 regulates metabolism through ER stress suppression.
Persistent activation of ER stress signalling can provoke excessive
fat accumulation and insulin resistance14,15. Tm-induced liver fat
accumulation became more prominent and persistent upon
Sestrin2 deficiency (Supplementary Fig. 10a,b). Although
neither Tm nor Sestrin2 deficiency significantly increased
the expression of genes responsible for hepatic lipogenesis
(Supplementary Fig. 10c) as previously reported12,22, serum
triglyceride level, which is usually decreased by Tm-induced
ER stress23, was even further lowered by loss of Sesn2
(Supplementary Fig. 10d). The rapid reduction in the plasma
lipid level upon ER stress reflects defective secretion of
lipoproteins from hepatocytes23,24, which also causes acute
hepatosteatosis. These results raise a possibility that Sestrin2
may control liver metabolism through regulating ER homeostasis.
Indeed, increased hepatosteatosis and hepatic insulin resistance
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phenotypes of obese Sesn2 / mice (Fig. 7a–d)12,25 were
strongly suppressed by liver-specific reconstitution of Sestrin2
(Fig. 7e–h) or TUDCA administration (Fig. 7i–l), either of which
can prevent hepatic ER stress. Thus, Sestrin2-mediated
suppression of hepatic ER stress is not only required to prevent
liver damage but also critical for proper regulation of lipid and
glucose homeostasis.
Discussion
Although Sestrin2 was originally identified as a protein inducible
upon DNA damage and oxidative stress26, these stress insults
turned out to be not responsible for Sestrin2 upregulation during
obesity. Rather, disruption of ER homeostasis was the critical
event responsible for obesity-induced Sestrin2 expression. An ER
stress sensor PERK and its downstream transcription factor
c/EBPb play essential roles in Sestrin2 upregulation upon
nutritionally or chemically induced ER stress. Other signalling
mediators of ER stress, such as IRE1, ATF6, ATF4, CHOP and
JNK, appeared not to be significantly involved in this process. As
Sestrin2 is the only Sestrin-family protein inducible upon obesity
or ER stress, loss of Sesn2 was not compensated by the presence
of Sestrin1 or Sestrin3. This allowed us to investigate the
physiological functions of Sestrin2 in the context of ER stress
using Sestrin2-deficient cells and mice.
Sestrin2-deficient cells cannot cease protein translation upon
prolonged ER stress insults even though they exhibit prominently
elevated PERK-eIF2a signalling activities. This finding was
particularly striking to us because it has been formerly believed
that ER stress-induced translation arrest is solely and directly
mediated by PERK-dependent phosphorylation of eIF2a (ref. 6).
However, according to our results, Sestrin2-mediated mTORC1
regulation can be another important mechanism that can
suppress protein translation during chronic ER stress. As
Sestrin2-deficient cells lack this mechanism, they exhibited
excessive ER stress that induces activation of the PERK-eIF2a
signalling as well as the other branches of ER stress signalling.
Increased ER stress observed in Sestrin2-deficient cells was
suppressible by genetic or pharmacological inhibition of
mTORC1. Therefore, Sestrin2-mediated mTORC1 regulation is
an important UPR mechanism downstream of the PERK–eIF2a–
c/EBPb signalling that prevents excessive accumulation of
unfolded proteins and aggravation of ER stress (Fig. 6i,j).
Recent reports have shown that deregulation of mTORC1 or
protein translation can promote accumulation of unfolded and
misfolded proteins, thereby further sensitizing cells to ER stress
insults27–29. Consistent with these, Sestrin2-deficient hepatocytes
were hypersusceptible to ER stress-induced cell death, and
Sesn2 / mice were prone to develop ER stress-induced liver
pathologies associated with hepatocyte death. The liver
pathologies were suppressed by either AICAR or TUDCA
administration, suggesting that defective AMPK-mTORC1
regulation and subsequent exacerbation of ER stress are the
causes of these pathologies.
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In summary, we have described a role for Sestrin2 as the
critical component of hepatic UPR that mediates ER stress-
induced suppression of protein synthesis. Sestrin2-mediated
UPR mechanism is important for suppression of obesity-
associated NAFLD pathologies including liver damage and
steatohepatitis as well as fat accumulation and insulin resistance.
Sestrin2’s protective role against ER stress may be also important
in other non-hepatic tissues that may experience increased
levels of ER stress during obesity. Considering that unresolved ER
stress is a possible pathogenetic cause of diverse diseases
including cancer, neurodegeneration, type 1/2 diabetes and
atherosclerosis9 and that obesity increases incidences of these
degenerative diseases30, it would be much of interest to
investigate possible protective roles of Sestrin2 against
progression of these degenerative diseases beyond the scope of
liver pathologies.
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Methods
Antibodies and reagents. Antibodies against Sestrin1 and Sestrin2 were gener-
ated from bacterially expressed recombinant proteins as described12. Antibodies
against phospho-PERK (Cell Signaling, Santa Cruz), PERK (Cell Signaling, Santa
Cruz), ATF4 (Santa Cruz), ATF6 (Santa Cruz), c/EBPb (Santa Cruz), RNA
polymerase II (Santa Cruz), SERCA2 (Santa Cruz), phospho-S6 kinase (Cell
Signaling, Santa Cruz), S6K (Santa Cruz), phospho-AMPKa (Santa Cruz), AMPKa
(Santa Cruz), CHOP (Cell Signaling, Santa Cruz), IRE1a (Santa Cruz), heavy
chain-binding protein (BiP; Cell Signaling), protein disulphide isomerase (Cell
Signaling), phospho-JNK (Cell Signaling), JNK (BD Biosciences), p53 (Santa Cruz),
phospho-c-Jun (Santa Cruz), c-Jun (Santa Cruz), phospho-S6 (Cell Signaling), S6
(Cell Signaling), phospho-eIF4E-binding protein (Cell Signaling), 4E-BP (Cell
Signaling), phospho-eIF2a (Cell Signaling), eIF2a (Santa Cruz), Raptor (Cell
Signaling), TSC2/tuberin (Santa Cruz), Sestrin2 (Proteintech), Sestrin3 (Abcam),
F4/80 (Invitrogen), a-SMA (Abcam), Actin (DSHB), puromycin (DSHB) and
Tubulin (Sigma) were used as primary antibodies. Horseradish peroxidase
(HRP)-conjugated secondary antibodies (Bio-Rad), biotin-conjugated secondary
antibodies (BD Biosciences), streptavidin-HRP (BD Biosciences) and Alexa
Flour-conjugated secondary antibodies (Invitrogen) were used for immunoblotting
and immunostaining procedures. Fatty acid free and low endotoxin bovine serum
albumin (BSA), PA, stearic acid, oleic acid, docosahexaenoic acid, Tm,
thapsigargin, insulin, glucose, Oil Red O, butylated hydroxyanisole and N-acetyl
cysteine were purchased from Sigma. Cycloheximide was from Amresco and PP242
was from Chemdea. TUDCA was purchased from EMD Millipore. SP600125,
rapamycin and AICAR were purchased from LC Labs. Salubrinal was purchased
from Calbiochem.
Cell culture. HepG2 cells (gift from Dr Saltiel) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Invitrogen) containing 10% fetal bovine serum
(fetal bovine serum, Sigma), 50Uml 1 penicillin and 50mgml 1 streptomycin.
De-lipidated low-endotoxin BSA was loaded with indicated fatty acids and applied
to cultured cells as described31.
Mice and diets. WT, Sesn2 / and Lepob/ob mice are in the C57BL/6 background
as described12. Male mice of indicated age were used for the study. Mice were
maintained in filter-topped cages and were given free access to autoclaved regular
chow diet (low-fat diet) or HFD (composed of 59% fat, 15% protein and 26%
carbohydrates based on caloric content; Bio-Serv) and water at the University of
Michigan (UM) according to the NIH and institutional guidelines. All animal
studies were overseen by the University Committee on Use and Care of Animals
at UM.
Lentiviruses. The lentiviral plasmids for sh-Sestrin2 (ref. 10), sh-p53 (ref. 32),
sh-c/EBPb33, sh-Raptor and sh-TSC2 (ref. 12) were previously described. Lentiviral
plasmids for sh-PERK (TRCN0000001401 and TRCN0000001399), sh-ATF6
(TRCN0000017853 and TRCN0000017855), sh-CHOP (TRCN0000007264) and
sh-ATF4 (TRCN0000013575) were purchased from Open Biosystems (Huntsville,
AL). Lentiviral IRE1aDN construct was obtained from Addgene (Cambridge, MA).
Lentiviruses were generated in the Vector Core facility at the UM.
Adenoviruses. Adenoviruses expressing AMPKCA (Ad-AMPKCA) were pur-
chased from Eton Biosciences. Adenoviruses expressing the 2b isoform of SERCA2
(Ad-SERCA2b) were gifts from Dr Hotamisligil15. Adenoviruses expressing
c/EBPb and sh-c/EBPb were gifts from Dr Lin34. Control adenoviruses were
supplied by the UM Vector Core. Adeno-associated viruses (AAVs) for green
fluorescent protein (GFP; AAV-Con) and Sestrin2 (AAV-Sesn2) were gifts from
Dr Pura Munoz (UPF, Spain). The viruses were amplified in the UM Vector Core.
For hepatic gene transfer, 109 plaque-forming units of viruses were injected into
mice through their tail vein.
Immunoblotting. Cells or tissues were lysed in RIPA buffer (50mM Tris-Cl, pH
7.4, 150mM NaCl, 1% sodium deoxycholate, 1% NP-40; 0.1% SDS) or cell lysis
buffer (20mM Tris-Cl, pH 7.5, 150mM NaCl, 1mM EDTA, 1mM EGTA,
2.5mM sodium pyrophosphate, 1mM b-glycerophosphate, 1mM Na3VO4,
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Figure 6 | Sestrin2 is an endogenous attenuator of steatohepatitis progression. (a,b) Livers fromWTand Sesn2 / mice kept on HFD (HFD panels) or
Lepob/ob/Sesn2þ / (Con) and Lepob/ob/Sesn2 / mice kept on LFD (Lepob panels) were subjected to anti-F4/80 staining to visualize macrophage
infiltration (a). F4/80-positive areas were quantified (b). (c–h) Livers from obese Sesn2 / mice transduced with AAV-Con (n¼4) or AAV-Sesn2 (n¼ 3)
(c,d) or injected with PBS (n¼4) or TUDCA (n¼ 5) (e,f) or PBS (n¼ 6) or AICAR (n¼ 5) (g,h) were analysed with anti-F4/80 staining (c,e,g).
F4/80-positive areas were quantified (d,f,h). Nuclei were visualized with haematoxylin (a,c,e,g). (i,j) Working model of how Sestrin2-mediated UPR
attenuates NAFLD progression. In the WT liver, Sestrin2 is induced during obesity through the PERK–c/EBPb pathway to attenuate protein translation
and thereby relieve ER stress (i). In Sesn2 / liver, persistent mTORC1 activity elevates protein synthesis and subsequently aggravates ER stress,
leading to facilitated NAFLD progression (j). Scale bars, 200mm. All data are shown as the mean±s.e.m. P values are from Student’s t-test.
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1% Triton-X-100) containing protease inhibitor cocktail (Roche). After being
clarified with centrifugation, lysates were boiled in SDS sample buffer, separated by
SDS–PAGE, transferred to polyvinylidene difluoride membranes and probed with
the indicated antibodies. Primary antibody dilution factors were 1:200 (all Santa
Cruz antibodies), 1:100 (anti-puromycin antibody) or 1:1,000 (all other antibodies).
After incubation with secondary antibodies conjugated with HRP (1:2,000),
chemiluminescence was detected and quantified using LAS4000 (GE) system.
Full-sized scans of all western blots are provided in Supplementary Fig. 11.
Quantitative reverse transcriptase/real-time PCR (qRT–PCR). Total RNA
was extracted from tissues or cells using Trizol reagent (Invitrogen), and cDNA
was made using MMLV-RT (Promega) and random hexamers (Invitrogen).
Quantitative PCR was performed in a Real-Time PCR detection system (Applied
Biosystems) with iQ SYBR Green Supermix (Bio-Rad) and relevant primers.
Relative mRNA expression was calculated from the comparative threshold cycle
(Ct) values relative to Cyclophilin A (CypA). Primers for human Sestrin1–3
(ref. 35), human CypA36, human XBP1 (ref. 37), mouse XBP1 (ref. 38), active
spliced form of mouse XBP1 (ref. 38) and human XBP1 (ref. 39), mouse BiP40,
mouse ER degradation-enhancing alpha-mannosidase-like 1 (ref. 40), mouse ER
oxidoreductin-1a (ref. 40), human CHOP36, mouse CHOP40, mouse protein
disulphide isomerase41, mouse ER-localized DnaJ homologue 4 (ref. 41), mouse
HMG-CoA reductase42, mouse sterol regulatory element-binding transcription
factor 1 (ref. 42), mouse Srebf2 (ref. 42), mouse fatty acid synthase43, mouse acetyl-
CoA carboxylase alpha (Acaca)43, mouse Acacb43, mouse b-Actin44 and mouse
CypA12 were designed as described. The ratio of spliced (XBP1-s) to unspliced
(XBP1-u) XBP1 levels was determined using semi-quantitative RT–PCR; PCR
products of XBP1-s and XBP1-u were separated using electrophoresis on a 2.5%
agarose gel and visualized with ethidium bromide staining. Percent of XBP1
splicing was quantified using ImageJ (NIH).
Histology. Liver tissues were fixed in 10% buffered formalin, embedded in paraffin
and stained with haematoxylin and eosin. To visualize collagen fibres, liver sections
were stained with saturated picric acid containing 0.5% Sirius Red (Sigma). The
sections were washed with distilled water, dehydrated, mounted and analysed with
light microscopy. For immunostaining of BiP, p-PERK and F4/80, paraffin-
embedded liver sections were incubated with corresponding primary antibodies
(1:200, 1:50 and 1:100, respectively), followed by incubation with biotin-conjugated
secondary antibodies (1:200) and streptavidin-HRP (1:300). The HRP activity was
visualized with diaminobenzidine staining. Haematoxylin counterstaining was
applied to visualize nuclei. For a-SMA staining, liver sections were incubated
with anti-a-SMA antibody (1:100), followed by incubation with Alexa Flour
594-conjugated secondary antibody (1:250) and counterstaining with 40 ,6-
diamidino-2-phenylindole (DAPI; Invitrogen). TdT-mediated dUTP nick end
labelling (TUNEL) assay was performed using In Situ Cell Death Detection
Kit-TMR-Red (Roche). Samples were analysed under an epifluorescence-equipped
light microscope (Olympus).
Glucose and insulin tolerance tests (GTTand ITT). For GTT and ITT, mice that
were made to fast for 6 h were injected with glucose (1 g per kg body weight
intraperitoneally (i.p.)) or insulin (0.65U per kg body weight i.p.). Blood glucose
was instantly measured at 0, 20, 40, 60 and 120min after glucose or insulin
injection using OneTouch Ultra glucose meter.
Oil Red O staining. Optimum cutting temperature compound (OCT)-embedded
frozen liver sections were allowed to air dry and were rinsed with 60% isopropanol,
followed by staining with fresh 0.5% Oil Red O solution for 15min. After staining,
the slides were rinsed with 60% isopropanol, washed with distilled water, mounted
and analysed under light microscope (Olympus).
Serum ALTassay. Serum ALT levels were measured with an ALT activity assay kit
(Sigma) according to the manufacturer’s instructions.
ROS detection. Intracellular level of ROS was measured using ROS indicator
chloromethyl-20 ,70-dichlorodihydrofluorescein diacetate (CM-H2DCFDA,
Invitrogen). Cells were treated with 5 mM CM-H2DCFDA for 30min at 37 C in the
dark and washed in phosphate-buffered saline, followed by observation under an
epifluorescence-equipped microscope (Olympus). Dihydroxyethidium staining of
liver tissues was carried out as described using freshly frozen sections45.
Primary cell culture. Primary mouse hepatocytes were isolated from livers of
2-month-old lean WT or Sesn2 / mice, as described46.
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Figure 7 | Sestrin2 controls liver metabolism through regulating ER homeostasis. (a–d) Six-month-old WT and Sesn2 / mice were kept on HFD
for 4 months. Livers were analysed with Oil Red O (ORO) staining (a). ORO densities were quantified (b) (n¼4). Mice were tested for insulin resistance
(ITT; c; n¼ 8) and for glucose tolerance (GTT; d; n¼ 8). Area-under-the-curve data for ITT (c) and GTT (d) were calculated. (e–h) Five-month-old
Sesn2 / mice kept on HFD for 3 months were transduced with AAV-Con (n¼4) or AAV-Sesn2 (n¼ 3). After 10 days, livers were harvested from the
treated mice and analysed with ORO staining (e). ORO densities were quantified (f). Mice were tested for insulin resistance at 5 days (g) and for glucose
tolerance at 7 days (h) after AAV transduction. Area-under-the-curve data for ITT (g) and GTT (h) were calculated. (i–l) Five-month-old Sesn2 / mice
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treatment, livers were harvested from the treated mice and analysed with ORO staining (i). ORO densities were quantified (j). Mice were tested for
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GTT (l) were calculated. Scale bars, 200mm; 10 mm (insets). All data are shown as the mean±s.e.m. P values are from Student’s t-test.
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Immunocytochemistry. For c/EBPb staining, HepG2 cells were fixed with
methanol and incubated with anti-c/EBPb antibody (1:100), followed by
incubation with Alexa Fluor 594-conjugated secondary antibody (1:500) and
counterstaining with DAPI (Invitrogen). Samples were analysed under an
epifluorescence-equipped light microscope (Olympus).
Measurement of protein synthesis. To label newly synthesized proteins with
L-azidohomoalanine (AHA) in cultured cells, cells were incubated with 25 mM
AHA (Invitrogen) in methionine- and cysteine-free DMEM (Invitrogen) for 3 h in
the presence of 10% fetal bovine serum and antibiotics. AHA-incorporated proteins
were labelled with biotin using Click-iT Biotin Protein Analysis Detection Kit
(Invitrogen). The biotin-labelled proteins were assayed by immunoblotting. To
label newly synthesized proteins with AHA in the mouse liver, mice were injected
with 13mg per kg body weight AHA (i.p.). After 15min, the liver was harvested
and analysed using Click-IT immunoblotting. To label nascent peptides with
puromycin, cultured cells were incubated with 1 mM puromycin (Calbiochem) in
normal culture medium, and mice were injected with 0.04mmol per kg body
weight puromycin (i.p.). After 30min, cells and livers were harvested and
puromycin-labelled proteins were detected using anti-puromycin immunoblotting.
Luciferase assay. The luciferase-based Sesn2 reporter constructs and c/EBPDN
plasmid were described previously47. HepG2 cells were transfected with
Sesn2-luciferase constructs and renilla luciferase expression vector (pTK-RL) using
Lipofectamine 2000 (Invitrogen). After 48 h, cells were treated with BSA or PA for
9 h. Luciferase activity was analysed using Dual-Luciferase reporter assay kit
(Promega).
Chromatin immunoprecipitation (ChIP). HepG2 cells were treated with BSA or
PA for 9 h and fixed with 1% paraformaldehyde for 10min at room temperature.
ChIP assays were performed using the EZ-ChIP Kit (EMD Millipore) according to
the manufacturer’s instructions. Chromatin extracts were immunoprecipitated with
anti-c/EBPb or anti-RNA polymerase II antibodies. Protein-associated DNA was
analysed with quantitative PCR using the following primers targeting sequences
between  278 and þ 13 bps from the transcription start site of the Sesn2 gene:
50-TCCCTTTTCATCACGCAACC-30 and 50-CTCTGACACCAGCAGTTCAGC-30 .
Statistical analysis. Statistical significance of differences between two groups was
calculated by a two-tailed Student’s t-test. P values equal to or above 0.05 were
considered not statistically significant.
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